Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.04
-0.09 (-1.47%)
At close: Nov 3, 2025, 4:00 PM EST
6.04
0.00 (0.00%)
After-hours: Nov 3, 2025, 4:10 PM EST
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $375.2 million as of November 3, 2025. Its market cap has decreased by -26.21% in one year.
Market Cap
375.20M
Enterprise Value
214.14M
1-Year Change
-26.21%
Ranking
Category
Stock Price
$6.04
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $375.20M, a decrease of -5.66%. That is a compound annual growth rate of -1.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 380.79M | -7.26% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |